Emery Pharma to Participate in 2023 ACS National Meeting & Expo, San Francisco
San Francisco, CA: Emery Pharma is excited to announce its participation in the prestigious American Chemical Society’s (ACS) National Meeting & Expo in San Francisco, California, taking place from August 13 to 17, 2023. With over 16,000 attendees from around the world, the ACS National Expo provides an excellent opportunity for professionals to connect, access state-of-the-art laboratory equipment, and discover cutting-edge advancements in the field. At the Moscone Convention Center, Emery Pharma will showcase its extensive range of scientific capabilities and services, reinforcing its position as a leading contract research organization.
Emery Pharma’s scientific team will be available throughout the exposition to answer any questions regarding their expanded offers. Please join us at booth #458 to learn more and hear about these offerings!
Emery Pharma will be highlighting its diverse capabilities, including:
Large Molecule Division: Our newly expanded Large Molecule Division includes comprehensive solutions for the analysis and characterization of large molecules, including proteins, peptides, and antibodies. Leveraging our newly acquired Thermo Scientific™ Exploris 240 UPLC-MS system with the Biopharma option, offering an unprecedented mass range for intact mass analyses (m/z up to 8000), we offer state-of-the-art analytical techniques and expertise to be your preferred partner in biopharmaceutical research and development.
Bioanalytical Chemistry: Our expertise in bioanalytical chemistry includes utilizing cutting-edge technologies and methodologies for quantitative analysis of small and large molecules across diverse complex matrices, including biological fluids and tissues. Adhering to strict regulatory guidelines, we ensure the highest level of accuracy and precision in our results. Our strategies range from Ligand binding assays (LBAs) such as ELISA, LC-MS/MS, LC-HRMS, to hybrid LC-MS or immunoaffinity-LC-MS.
cGMP-GLP NMR: We provide cGMP-GLP (Current Good Manufacturing Practice-Good Laboratory Practice) Nuclear Magnetic Resonance (NMR) services with our qualified 400 MHz, rigorously adhering to pharmaceutical research and development standards.
Customized Method Development/Validation Services: We take pride in our ability to tailor analytical methods and validation protocols to meet your specific project requirements. With a team of experienced scientists, we can develop and validate methods for a wide range of compounds and matrices, providing precise results aligned with the unique needs of clients.
Expert Consultation: Our scientific team goes beyond comprehensive analytical services, offering expert consultation to clients. Whether seeking guidance on study design, data interpretation, or regulatory compliance, we are equipped to provide valuable insights and support throughout the drug development process.
About Emery Pharma: Emery Pharma is a full-service contract research laboratory, supporting the end-to-end development of small molecule drugs, biologics, biosimilars, gene therapy, botanicals, and more. Emery Pharma specializes in supporting preclinical drug development, including analytical, bioanalytical solutions, microbiology & cell biology services, drug & impurity characterization, and general R&D and cGMP/GLP support. https://emerypharma.com/contact/
Stay connected with Emery Pharma: Emery Pharma looks forward to connecting with attendees at the ACS National Meeting & Expo in San Francisco, California!
Contact us at: +1-510-899-8814 or 1-888-983-6379